Bioline Rx reported $33.48M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Arca Biopharma USD 1.14B 634.91M Jun/2026
Bio Path USD 677K 13K Mar/2026
Bioline Rx USD 33.48M 5.32M Jun/2026
Capricor Therapeutics USD 368.74M 42.45M Jun/2026